Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...